VISTAS Phase 2b Trial Results May 2026
New trial data shows volixibat significantly reduces severe itch for people with PSC.
2027 TCS London Marathon Charity Places
Applications now open for our 2027 TCS London Marathon charity places!
April 2026 Research Roundup
Discover how PSC Support is accelerating research, from novel diagnostics to gut health, this month.
Upcoming Ask the Expert Live – PSC Q&A
Register for our upcoming Ask the Expert live PSC Q&A with Dr Joshi, taking place on 2nd May at 1pm (UK).
Advancing PSC Research: New Funding Awards for 2025
PSC Support announces new research funding, pushing our total Mission 2030 investment to £852,588.
SABR-PSC Clinical Trial Results
Early-phase study shows brodalumab is safe and well-tolerated in people with PSC.
Jenny & Sophie: Loom Bands, Cakes & Community for Rare Disease Day
To mark Rare Disease Day, Jenny stood up in front of her local church to share her personal experience of living with PSC. Her daughter Sophie was on hand selling and making bespoke loom band bracelets and key chains after being inspired by Liyana.
March 2026 Research Roundup
A summary of recent clinical trial results, new research funding, and a historic NICE evaluation.
Ritivixibat (A3907) Phase 2 Clinical Trial Results
Safety results for the Phase 2 ritivixibat study (A3907) for PSC have been released.
PSC and GLP-1 Medication for Weight Loss
Exploring the role of GLP-1 medications and what the latest research means for our community.